ClinicalTrials.Veeva

Menu

Dose and Duration of Metronidazole and Amoxicillin for Treatment of Chronic Periodontitis

U

University of Guarulhos

Status and phase

Unknown
Phase 4

Conditions

Chronic Periodontitis

Treatments

Drug: Metronidazole 250 (7 days)
Drug: Metronidazole 250 (14 days)
Other: Placebo 500
Procedure: Scaling and root planing (SRP)
Drug: Amoxicillin
Other: Placebo 400 (14 days)
Other: Placebo 400 (7 days)
Drug: Metronidazole 400 (7 days)
Other: Placebo 250 (7 days)
Drug: Metronidazole 400 (14 days)

Study type

Interventional

Funder types

Other

Identifiers

NCT02735395
SISNEP/513

Details and patient eligibility

About

The aim of this study was to compare the clinical and microbiological outcomes of different dosages of metronidazole (MTZ) and of the duration of the systemic administration of MTZ and amoxicillin as adjunct to scaling and root planing (SRP) in the treatment of generalized chronic periodontitis (GChP).

Full description

Randomized clinical trials and systematic reviews have shown that the use of the combination of metronidazole (MTZ) and amoxicillin (AMX) significantly improves the benefits of the SRP in the treatment of subjects with periodontitis. However, the optimal dosage and interval of administration of these antibiotics are still unclear. Therefore, the aim of this study was to compare the clinical and microbiological outcomes of different dosages and duration of the systemic administration of the combination of MTZ and AMX as adjunct to scaling and root planing (SRP) in the treatment of generalized chronic periodontitis (GChP). One hundred ten subjects will be randomly assigned to receive SRP plus placebo, or SRP combined with 250 mg or 400 mg of MTZ, plus AMX (500 mg) TID, for either 7 or 14 days. Subjects will be clinically and microbiologically monitored up to 1 year post-therapy.

Enrollment

110 patients

Sex

All

Ages

30+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ≥30 years of age;
  • at least 15 teeth (excluding third molars and teeth with advanced decay indicated for extraction)
  • a minimum of 6 teeth with at least one site each with probing depth (PD) and clinical * attachment level (CAL) ≥5 mm;
  • at least 30% of the sites with PD and CAL ≥4 mm and bleeding on probing (BOP).

Exclusion criteria

  • pregnancy
  • breastfeeding
  • current smoking and former smoking within the past 5 years;
  • systemic diseases that could affect the progression of periodontitis (e.g. diabetes, immunological disorders, osteoporosis);
  • scaling and root planing an in the previous 12 months;
  • antibiotic therapy in the previous 6 months;
  • long-term intake of anti-inflammatory medications;
  • need for antibiotic pre-medication for routine dental therapy;
  • allergy to metronidazole and/or amoxicillin.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

110 participants in 5 patient groups, including a placebo group

Control
Placebo Comparator group
Description:
Scaling and root planing (SRP) + two placebo pills thrice a day (TID) for 14 days (control group)
Treatment:
Other: Placebo 500
Procedure: Scaling and root planing (SRP)
Other: Placebo 400 (14 days)
MTZ 250 (7 days)
Active Comparator group
Description:
SRP + MTZ (250mg/TID) + AMX, for 7 days and placebos for another 7 days
Treatment:
Other: Placebo 250 (7 days)
Drug: Metronidazole 250 (7 days)
Procedure: Scaling and root planing (SRP)
Drug: Amoxicillin
MTZ 400 (7 days)
Active Comparator group
Description:
SRP + MTZ (400mg/TID) + AMX, for 7 days and placebos for another 7 days
Treatment:
Drug: Metronidazole 400 (7 days)
Procedure: Scaling and root planing (SRP)
Other: Placebo 400 (7 days)
Drug: Amoxicillin
MTZ 250 (14 days)
Active Comparator group
Description:
SRP +MTZ (250mg/TID) + AMX for 14 days
Treatment:
Drug: Metronidazole 250 (14 days)
Procedure: Scaling and root planing (SRP)
Drug: Amoxicillin
MTZ 400 (14 days)
Active Comparator group
Description:
SRP +MTZ (400mg/TID) + AMX for 14 days
Treatment:
Drug: Metronidazole 400 (14 days)
Procedure: Scaling and root planing (SRP)
Drug: Amoxicillin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems